Digital Therapeutics by the Numbers: The 2026 Data Brief
The verified statistics that define digital therapeutics in 2026, with sources.
Numbers cut through narrative. These are the verified data points our research desk considers most decision-relevant in digital therapeutics right now - each drawn from primary sources and our own reporting.
The numbers
1. There are 192 FDA-cleared digital therapeutics devices, but only seven are currently eligible for Medicare DMHT payment.
2. Medicare DMHT patient billing grew from 99 patients in Q1 2025 to 446 by Q3 (our coverage).
3. Boehringer Ingelheim put $50 million into Click Therapeutics to commercialize its schizophrenia DTx (our coverage).
4. A Canadian randomized trial showed digital CBT-I built for adults 65+ meaningfully cut insomnia and anxiety (our coverage).
How to read them
Individually, each figure is a snapshot. Together they describe a category where capital is concentrating, regulation is catching up, and proof is displacing promise. When these numbers move, strategy should move with them - which is why each links to the underlying coverage.
For continuously updated developments, follow Digital Therapeutics and its topic feeds.